Mirae Asset Global Investments Co., Ltd. Fulgent Genetics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$21.55 - $29.29 $926,606 - $1.26 Million	42,998 Added 98.18%	86,792 $1.88 Million
Q4 2023 Jan 24, 2024	SELL	$23.64 - $30.27 $1.41 Million - $1.8 Million	-59,588 Reduced 57.64%	43,794 $1.27 Million
Q3 2023 Oct 26, 2023	BUY	$26.74 - $40.81 $229,990 - $351,006	8,601 Added 9.07%	103,382 $2.76 Million
Q2 2023 Aug 10, 2023	BUY	$28.52 - $40.7 $208,595 - $297,679	7,314 Added 8.36%	94,781 $3.51 Million
Q1 2023 May 04, 2023	BUY	$29.39 - $36.27 $21,131 - $26,078	719 Added 0.83%	87,467 $2.73 Million
Q4 2022 Feb 09, 2023	SELL	$29.23 - $40.28 $645,164 - $889,060	-22,072 Reduced 20.28%	86,748 $2.58 Million
Q3 2022 Nov 10, 2022	BUY	$37.92 - $63.74 $537,743 - $903,896	14,181 Added 14.98%	108,820 $4.15 Million
Q2 2022 Jul 26, 2022	BUY	$47.98 - $62.75 $4.54 Million - $5.94 Million	94,639 New	94,639 $5.16 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.